BTIG Research reiterated their buy rating on shares of Strategy (NASDAQ:MSTR – Free Report) in a report published on Wednesday morning,Benzinga reports. Several other research firms have also recently weighed in on MSTR. HC Wainwright reissued a “buy” rating on shares of Strategy in a report on Friday, February 6th. Truist Financial set a $268.00 […]

Guggenheim reiterated their buy rating on shares of Neumora Therapeutics (NASDAQ:NMRA – Free Report) in a report issued on Tuesday,Benzinga reports. Guggenheim currently has a $14.00 price objective on the stock. NMRA has been the topic of a number of other research reports. Leerink Partners assumed coverage on shares of Neumora Therapeutics in a report […]

MoonLake Immunotherapeutics (NASDAQ:MLTX – Get Free Report)‘s stock had its “buy” rating reissued by equities researchers at BTIG Research in a research report issued on Monday,Benzinga reports. They currently have a $30.00 target price on the stock. BTIG Research’s price target points to a potential upside of 73.21% from the company’s current price. Several other […]